AstraZeneca and insitro have formed an AI-focused partnership to develop treatments for heart and liver diseases in a deal potentially worth up to $1.5 billion.
Quantum Computing Inc. and INmune Bio have partnered to use quantum optimization to identify new therapeutic applications for the experimental Alzheimer’s drug XPro.
Johnson & Johnson shares fell over 5% despite beating third-quarter earnings estimates, as medical technology sales lagged behind pharmaceutical growth.
Zealand Pharma has partnered with Generate Biomedicines in a deal worth up to $1.2 billion to leverage AI for developing new obesity treatments.
French biotech startup Rivercell has raised €22 million in a seed round to advance its AI-powered platform for predicting cellular responses to drugs.
Global pharmaceutical companies are increasingly acquiring assets from Chinese biotech firms, with licensing deal values surging 36% to over $120 billion this year.
Multiply Labs has raised $75 million in a Series B round led by Patrick Soon-Shiong to scale its robotic automation technology for pharmaceutical manufacturing.
The future of the orbital research economy depends on adopting terrestrial pharmaceutical standards to ensure data reproducibility and regulatory compliance.
Apheris and Ginkgo Datapoints have launched the Antibody Developability Consortium, uniting global pharma leaders to build a standardized 10,000-antibody dataset for AI training.
The US Treasury is drafting rules to allow most pharma licensing deals with China, exempting only pathogen-related and weaponizable biotech from the ongoing investment scrutiny.
Novo Nordisk is partnering with Anthropic to utilize the Claude Science platform for accelerating drug discovery and enhancing pharmaceutical research efficiency.
Novo Nordisk is partnering with Anthropic to integrate Claude AI models into its drug discovery and development workflows to accelerate the research process.
Novo Nordisk is partnering with Anthropic to integrate Claude AI models into its drug development pipeline and internal software operations.
